Company: IOBT
Filing Date: 2025-04-25
Form Type: DEF 14A
Source: 0000950170-25-058699
Chunk: 33

Company: IO Biotech, Inc.
Filing Date: 2025-04-25
Form: DEF 14A
Chunk 33
---
-based awards (e.g., as part of a new hire package or as a retention or promotional incentive). Stock options may be granted only with an exercise price at or above the closing market price of our common stock on the date of grant . During 2024, no stock option grants were made to any of our named executive officers during any period beginning four business days before the filing or furnishing of a periodic report or current report and ending one business day after the filing or furnishing of any such report with the SEC.

<div align='center'>25</div>

EQUITY COMPE NSATION PLAN INFORMATION The following table provides information as of December 31, 2024 regarding the number of shares of our common stock that may be issued under our equity compensation plans.

| Plan Category                             |     | A                       
 Number of Securities    
 to be Issued upon       
 Exercise of Outstanding 
 Options and Warrants    
 (in thousands)          |       |     | B                   
 Weighted Average    
 Exercise Price of   
 Outstanding Options 
 and Warrants        |      |     | C                      
 Number of Securities   
 Remaining Available    
 for Future Issuance    
 Under Equity           
 Compensation Plans     
 (Excluding Securities  
 Reflected in Column A) 
 (in thousands)         |       |     |    |
|:------------------------------------------|:----|:------------------------|------:|:----|:--------------------|-----:|:----|:-----------------------|------:|:----|---:|
| Equity compensation plans approved by     
 stockholders(1)                           |     |                         | 8,370 |     | $                   | 5.43 |     |                        | 1,195 |     | -1 |
| Equity compensation plans not approved by 
 stockholders(2)                           |     |                         |   598 |     |                     | 1.71 |     |                        | 1,666 |     |    |
| Total                                     |     |                         | 8,968 |     | $                   | 5.18 |     |                        | 2,861 |     |    |

(1) Includes 771,816 shares available under our IO Biotech, Inc. 2021 Employee Stock Purchase Plan (“ESPP”). Our ESPP provides the opportunity for eligible employees to acquire shares of our common stock at a discount of up to 15%. (2) Includes securities issuable pursuant to Nasdaq Listing Rule 5635(c)(4) under inducement awards and/or pursuant to